Overview

Topical Safety Study of Topical Diltiazem Hydrochloride

Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study will be to determine the potential of Diltiazem Hydrochloride 2% Cream to induce sensitization by repeated topical application to the skin of healthy subjects under controlled conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Ventrus Biosciences, Inc
Treatments:
Diltiazem